Literature DB >> 25814704

Skin prick test in patients with chronic allergic skin disorders.

Pooja Bains1, Alka Dogra1.   

Abstract

BACKGROUND: Chronic allergic skin disorders are the inflammatory and proliferative conditions in which both genetic and environmental factors play important roles. Chronic idiopathic urticaria (CIU) and atopic dermatitis (AD) are among the most common chronic allergic skin disorders. These can be provoked by various food and aeroallergens. Skin prick tests (SPTs) represent the cheapest and most effective method to diagnose type I hypersensitivity. Positive skin tests with a history suggestive of clinical sensitivity strongly incriminate the allergen as a contributor to the disease process. AIMS AND
OBJECTIVES: To determine the incidence of positive SPT in patients with chronic allergic skin disorders and to identify the various allergens implicated in positive SPT.
METHODS: Fifty patients of chronic allergic disorders were recruited in this study. They were evaluated by SPT with both food and aeroallergens.
RESULTS: In our study, SPT positivity in patients of CIU was 63.41% and in AD was 77.78%. Out of the 41 patients of CIU, the most common allergen groups showing SPT positivity were dust and pollen, each comprising 26.83% patients. SPT reaction was positive with food items (21.6%), insects (17.07%), fungus (12.20%), and Dermatophagoides farinae, that is, house dust mite (HDM) (7.32%). The allergen which showed maximum positivity was grain dust wheat (19.51%). Among nine patients of AD, maximum SPT positivity was seen with Dermatophagoides farinae, pollen Amaranthus spinosus, grain dust wheat, and cotton mill dust; each comprising 22.22% of patients.
CONCLUSION: Our study showed that a significant number of patients of CIU and AD showed sensitivity to dust, pollen, insects, Dermatophagoides farinae, and fungi on SPT. Thus, it is an important tool in the diagnosis of CIU and AD.

Entities:  

Keywords:  Atopic dermatitis; chronic idiopathic urticaria; skin prick test

Year:  2015        PMID: 25814704      PMCID: PMC4372908          DOI: 10.4103/0019-5154.152513

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  12 in total

1.  Prevalence and clinical characteristics of adult-onset atopic dermatitis with positive skin prick testing to mites.

Authors:  Kanokvalai Kulthanan; Leena Chularojanamontri; Araya Manapajon; Piyavadee Nuchkull
Journal:  Asian Pac J Allergy Immunol       Date:  2011-12       Impact factor: 2.310

Review 2.  Allergic triggers in atopic dermatitis.

Authors:  Jean-Christoph Caubet; Philippe A Eigenmann
Journal:  Immunol Allergy Clin North Am       Date:  2010-08       Impact factor: 3.479

Review 3.  Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis.

Authors:  D Y Leung; J M Hanifin; E N Charlesworth; J T Li; I L Bernstein; W E Berger; J Blessing-Moore; S Fineman; F E Lee; R A Nicklas; S L Spector
Journal:  Ann Allergy Asthma Immunol       Date:  1997-09       Impact factor: 6.347

Review 4.  Allergic skin disorders.

Authors:  A P Kaplan; R H Buckley; K P Mathews
Journal:  JAMA       Date:  1987-11-27       Impact factor: 56.272

5.  The natural history and response to therapy of chronic urticaria and angioedema.

Authors:  J H Quaranta; A S Rohr; G S Rachelefsky; S C Siegel; R M Katz; S L Spector; M R Mickey
Journal:  Ann Allergy       Date:  1989-05

6.  The prevalence of food hypersensitivity in an unselected population of children and adults.

Authors:  M Osterballe; T K Hansen; C G Mortz; A Høst; C Bindslev-Jensen
Journal:  Pediatr Allergy Immunol       Date:  2005-11       Impact factor: 6.377

Review 7.  [Allergic and pseudo-allergic reactions to foods in chronic urticaria].

Authors:  D-A Moneret-Vautrin
Journal:  Ann Dermatol Venereol       Date:  2003-05       Impact factor: 0.777

8.  Etiological approach to chronic urticaria.

Authors:  D S Krupa Shankar; Mukesh Ramnane; Eliz Aryal Rajouria
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

9.  Prevalence and relevance of the positivity of skin prick testing in patients with chronic urticaria.

Authors:  Kanokvalai Kulthanan; Sukhum Jiamton; Ni-on Rutnin; Metavee Insawang; Sumrauy Pinkaew
Journal:  J Dermatol       Date:  2008-06       Impact factor: 4.005

10.  Skin test positivity to aeroallergens in the patients with chronic urticaria without allergic respiratory disease.

Authors:  Z Caliskaner; S Ozturk; M Turan; M Karaayvaz
Journal:  J Investig Allergol Clin Immunol       Date:  2004       Impact factor: 4.333

View more
  4 in total

1.  Comparison of results and clinical value of skin prick tests with synthetic and native food allergens in patients at the age of up to 3 years.

Authors:  Ewa Łoś-Rycharska; Anna Sterkowicz; Bartosz Romańczuk; Mieczysława Czerwionka-Szaflarska
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

Review 2.  Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review.

Authors:  Melanie Mitsui Wong; Paul Kevin Keith
Journal:  Allergy Asthma Clin Immunol       Date:  2020-08-04       Impact factor: 3.406

3.  Sensitization to Fungi in Atopic Dermatitis Patients 14 Year and Older - Association with Other Atopic Diseases and Parameters.

Authors:  Jarmila Celakovská; Bukac Josef; Karel Ettler; Jaroslava Vaneckova; Kvetuse Ettlerova; Krejsek Jan
Journal:  Indian J Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.494

4.  Role of the Skin Prick Test in Urticaria Patients.

Authors:  Samruddhi Lote; Sanjeev B Gupta; Divya Poulose; Mahendra Singh Deora; Aditi Mahajan; Jaya Madhurya Gogineni; Sujay Saxena; Biswajit Chaklader
Journal:  Cureus       Date:  2022-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.